May. 21 at 9:28 AM
$NXGL "May 19, 2026: Positive Clinical Study Data:
NEXGEL reported results from a randomized, single-center IRB study on its hydrogel laser treatment patch for laser hair removal. The patch achieved a 95.6% reduction in plume concentration (p=0.0001) vs. control, plus greater hair reduction (37.2% vs. 26.7%) and lower pain scores (3.5 vs. 5.1). No adverse events, data published in Lasers in Surgery and Medicine.
This addresses safety concerns around laser plume (airborne particles). CEO Adam Levy highlighted its potential as a low-cost safety solution amid growing regulations."
After this study, NXGL should start selling in Europe and Asia by representatives there, like they do in Canada.
The laser plume is a crucial issue, directly related with carcinogenesis, therefore, this is great news also for companies related with skin laser, like
$INMD $LASE (thru its subsidiary CMS Laser),
$BHC
and potentially
$APYX
